Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents

Yen Wen Liu, Mu Shiang Huang, Ling Wei Hsu, Hsien Yuan Chang, Cheng Han Lee, Chi Ying Lee, Dao Peng Chen, Yi Heng Li, Ting Hsin Chao, Pei Fang Su, Meng Ru Shen, Ping Yen Liu

研究成果: Article同行評審

6 引文 斯高帕斯(Scopus)


The new generation, i.e., second- and third-generation, drug-eluting stents (DESs) remain a risk of in-stent restenosis (ISR). We evaluated the power of a genetic risk score (GRS) model to identify high-risk populations for new generation DES ISR. We enrolled patients with coronary artery disease (CAD) treated with new generations DESs by a single-center cohort study in Taiwan and evaluated their genetic profile. After propensity score matching, there were 343 patients and 153 patients in the derivation and validation cohorts, respectively. Five selected single-nucleotide polymorphisms (SNPs), i.e., SNPs in CAMLG, GALNT2, C11orf84, THOC5, and SAMD11, were included to calculate the GRS for new generation DES ISR. In the derivation and the validation cohorts, patients with a GRS greater than or equal to 3 had significantly higher new generation DES ISR rates. We provide biological information for interventional cardiologists prior to percutaneous coronary intervention by specific five SNP-derived GRS.

出版狀態Published - 2021 9月 24

All Science Journal Classification (ASJC) codes

  • 多學科


深入研究「Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents」主題。共同形成了獨特的指紋。